Krutskikh, E.P.; Potanina, D.V.; Samoylova, N.A.; Gryaznova, M.V.; Sadovnikova, I.S.; Gureev, A.P.; Popov, V.N.
Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment. Pharmaceuticals 2022, 15, 815.
https://doi.org/10.3390/ph15070815
AMA Style
Krutskikh EP, Potanina DV, Samoylova NA, Gryaznova MV, Sadovnikova IS, Gureev AP, Popov VN.
Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment. Pharmaceuticals. 2022; 15(7):815.
https://doi.org/10.3390/ph15070815
Chicago/Turabian Style
Krutskikh, Ekaterina P., Daria V. Potanina, Natalia A. Samoylova, Mariya V. Gryaznova, Irina S. Sadovnikova, Artem P. Gureev, and Vasily N. Popov.
2022. "Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment" Pharmaceuticals 15, no. 7: 815.
https://doi.org/10.3390/ph15070815
APA Style
Krutskikh, E. P., Potanina, D. V., Samoylova, N. A., Gryaznova, M. V., Sadovnikova, I. S., Gureev, A. P., & Popov, V. N.
(2022). Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment. Pharmaceuticals, 15(7), 815.
https://doi.org/10.3390/ph15070815